...
首页> 外文期刊>Journal of trace elements in medicine and biology: Organ of the Society for Minerals and Trace Elements (GMS) >In vivo bio-distribution, clearance and toxicity assessment of biogenic silver and gold nanoparticles synthesized from Abutilon indicum in Wistar rats
【24h】

In vivo bio-distribution, clearance and toxicity assessment of biogenic silver and gold nanoparticles synthesized from Abutilon indicum in Wistar rats

机译:在Wistar大鼠中从Abutilon Indimum中合成的生物分布,对生物分布,清除和毒性评估,在Wistar大鼠中合成

获取原文
获取原文并翻译 | 示例

摘要

This study reports the bio-distribution and clearance of Abutilon indicum silver and gold nanoparticles (AIAgNPs and AIAuNPs) in Wistar rats. Rats in different groups were orally administered with 5 and 10 mg/Kg BW of AIAgNPs and AIAuNPs (size 1-25 nm) for 28 days and few were maintained until 58 days of washout period. Serum biochemical parameters were not changed significantly at both doses of AIAuNPs and at lower concentration of AIAgNPs. But, with 10 mg/Kg BW of AIAgNPs rats showed elevated levels of AST, ALP and ALT on day 29, however, these levels were restored to normal after washout period. Liver oxidative stress markers were not altered with the treatment of AIAgNPs and AIAuNPs. ICP-OES analysis indicated bio-distribution of Ag and Au more in liver, kidney and spleen on day 29 and was found cleared on day 59. Histological analysis of nine vital organs indicated normal tissue architecture at both doses of AIAuNPs and lower dose of AIAgNPs. While the rats treated with higher dose of AIAgNPs showed mild liver sinusoid cell swelling on day 29, which also was recovered on day 59. Findings of this preclinical study indicate biocompatible nature of biogenic nanoparticles supporting their future biomedical applications.
机译:本研究报告了Wistar大鼠中Abutilon Indigum银和金纳米粒子(Aiagnps和AiaUnps)的生物分布和清除。将不同组的大鼠口服给予5-10mg / kg的AIAGNP和AiaUnps(尺寸1-25nm)28天,并且少量保持在58天的冲洗期。在AiaUnps两种剂量和较低浓度的AiaGnPS中,血清生化参数没有显着变化。但是,对于10mg / kg的Aiagnps大鼠,在第29天显示AIAGNPS大鼠的升高,ALP和ALT水平,然而,在洗涤期后,这些水平恢复到正常。肝脏氧化应激标记物未通过治疗AIAGNP和AIAUNP来改变。 ICP-OES分析表明,第29天的肝脏,肾脏和脾脏的生物分布和Au更多的生物分布,并在第59天进行了清除。九个重要器官的组织学分析表明两种剂量的AiaUnps和低剂量的AiaGnPs 。虽然用更高剂量的AiaGnP治疗的大鼠在第29天显示出轻度肝脏正弦细胞溶胀,但在第59天也被回收。该临床前研究的结果表明了支持其未来生物医学应用的生物相容性纳米粒子的生物相容性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号